 ?您的位置：對照品 > 標準品 > dr標準品 > |
|
|
|
| 產(chǎn)品基本信息 |
|
| 產(chǎn)品編號：R504000 |
| 產(chǎn)品名稱：Rifalazil |
| 產(chǎn)品CAS：129791-92-0 |
| 規(guī)格含量：50mg |
| 產(chǎn)品價格：面議 |
| 聯(lián)系我們: |
 |
|
 |
|
|
| 產(chǎn)品詳細介紹 |
| 標準品編號: |
R504000 |
| 名稱: |
Rifalazil |
| 別名: |
1',4-Didehydro-1-deoxy-1,4-dihydro-3'-hydroxy-5'-[4-(2-methylpropyl)-1-piperazinyl]-1-oxorifamycin VIII; 2,7-(Epoxypentadeca[1,11,13]trienimino)-6H-benzofuro[4,5-a]phenoxazine, rifamycin VIII deriv.; ABI 1648; Isobutylpiperazinyl rifa; KRM 1648 |
| CAS號: |
129791-92-0 |
| 分子式: |
C??H??N?O?? |
| 分子量: |
941.07 |
| 類別: |
Standards; Pharmaceutical/API Drug Impurities/Metabolites; |
| 應(yīng)用: |
Rifalazil has been used as a part of multi drug regimen in the treatment of tuberculosis. |
| 參考文獻 |
|
|
|
|
|
|
